Faa. Vanacker et al., CHEMOKINES - STRUCTURE, RECEPTORS AND FUNCTIONS - A NEW TARGET FOR INFLAMMATION AND ASTHMA THERAPY, Mediators of inflammation, 5(6), 1996, pp. 393-416
FIVE to 10% Of the human population have a disorder of the respiratory
tract called 'asthma'. It has been known as a potentially dangerous d
isease for over 2000 years, as it was already described by Hippocrates
and recognized as a disease entity by Egyptian and Hebrew physicians.
At the beginning of this decade, there has been a fundamental change
in asthma management. The emphasis has shifted from symptom relief wit
h bronchodilator therapies (e.g. beta(2)-agonists) to a much earlier i
ntroduction of antiinflammatory treatment (e.g. corticosteroids). Asth
ma is now recognized to be a chronic inflammatory disease of the airwa
ys, involving various inflammatory cells and their mediators. Although
asthma has been the subject of many investigations, the exact role of
the different inflammatory cells has not been elucidated completely.
Many suggestions have been made and several cells have been implicated
in the pathogenesis of asthma, such as the eosinophils, the mast cell
s, the basophils and the lymphocytes. To date, however, the relative i
mportance of these cells is not completely understood. The cell type p
redominantly found in the asthmatic lung is the eosinophil and the rec
ruitment of these eosinophils can be seen as a characteristic of asthm
a. In recent years much attention is given to the role of the newly id
entified chemokines in asthma pathology. Chemokines are structurally a
nd functionally related 8-10 kDa peptides that are the products of dis
tinct genes clustered on human chromosomes 4 and 17 and can be found a
t sites of inflammation. They form a superfamily of proinflammatory me
diators that promote the recruitment of various kinds of leukocytes an
d lymphocytes. The chemokine superfamily can be divided into three sub
groups based on overall sequence homology. Although the chemokines hav
e highly conserved amino acid sequences, each of the chemokines binds
to and induces the chemotaxis of particular classes of white blood cel
ls. Certain chemokines stimulate the recruitment of multiple cell type
s including monocytes, lymphocytes, basophils, and eosinophils, which
are important cells in asthma Intervention in this process, by the dev
elopment of chemokine antagonists, might be the key to new therapy. In
this review we present an overview of recent developments in the fiel
d of chemokines and their role in inflammations as reported in literat
ure.